Pharmacokinetic/Pharmacodynamic adequacy of novel -lactam/-lactamase inhibitors against gram-negative bacterial in critically ill patients.
Release Time:2025-04-30
Hits:
- Date:
- 2025-04-30
- Title of Paper:
- Pharmacokinetic/Pharmacodynamic adequacy of novel -lactam/-lactamase inhibitors against gram-negative bacterial in critically ill patients.
- Journal:
- Antibiotics
- Co-author:
- Ruiying Han, Yalin Dong*
- Translation or Not:
- No
- Date of Publication:
- 2021-08-17
- Prev One:Determining the optimal PD-1/PD-L1 inhibitors for first-line treatment of non-small-cell lung cancer with high level PD-L1 expression in China.
- Next One:Determination of tigecycline in human lung epithelial cells and polymorphonuclear neutrophils by LC-MS/MS and its application in cellular pharmacokinetic study.